Person

John G. Stratton

Director, Abbott Laboratories

Current S&P 500 boards
2
Current roles
2
Open-market buys
$926K
Open-market sales
$0

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

  • VZ
    Verizon
    EVP&Pres - Global Operations
    2016 or earlier – last filing Jun 2018

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
May 7, 2026ABTBuy2,000$86.82$174K
Mar 3, 2020GDBuy3,048$164.81$502K
Jan 31, 2019ABTBuy100$72.32$7K
Jan 31, 2019ABTBuy100$72.31$7K
Jan 31, 2019ABTBuy842$72.32$61K
Jan 31, 2019ABTBuy613$72.31$44K
Jan 31, 2019ABTBuy1,800$72.33$130K

SEC reporting-owner ID (CIK) 1385262 · all filings on EDGAR